- Nachrichtendetail
-
26.04.2024 15:02:59 - dpa-AFX: *AMGEN TO SUBMIT MAA TO EMA FOR TEPROTUMUMAB IN THYROID EYE DISEASE TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AMGEN INC. DL-,0001 | 867900 | Xetra | 288,000 | 14.05.24 12:09:10 | +0,700 | +0,24% | 285,600 | 287,900 | 284,050 | 287,300 |
